Aav9-mediated schwann cell-targeted gene therapy rescues a model of demyelinating neuropathy

HIGHLIGHTS

• who: Alexia Kagiava from the Neuroscience Department, The Cyprus Institute of Neurology and Genetics and Cyprus School of Molecular Medicine, Nicosia, Cyprus Department of Molecular Virology, The Cyprus Institute of Neurology and Genetics and Cyprus School of Molecular Medicine, Nicosia, Cyprus Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, United Kingdom have published the article: AAV9-mediated Schwann cell-targeted gene therapy rescues a model of demyelinating neuropathy, in the Journal: (JOURNAL)
• what: This study provides evidence that a clinically translatable AAV9 . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.